Pediatric bowel preparation: Sodium picosulfate, magnesium oxide, citric acid vs polyethylene glycol, a randomized

Carmen Cuffari1, Steven L Ciciora2, Masakazu Ando3

  • 1Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, MD 21287, United States. ccuffari@jhmi.edu.

Insights

Sodium picosulfate, magnesium oxide, and citric acid (SPMC) is an effective and safe bowel preparation for children aged 9-16. This new option demonstrated higher tolerability compared to polyethylene glycol (PEG).

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Trial Research
  • Pharmacology

Background:

  • Bowel preparation in pediatric patients presents unique challenges.
  • Effective and safe methods are crucial for successful colonoscopy in children.

Purpose of the Study:

  • To evaluate the efficacy, safety, and tolerability of sodium picosulfate, magnesium oxide, and citric acid (SPMC) for bowel preparation in children aged 9-16 years.
  • To compare SPMC with polyethylene glycol (PEG)-based preparations.

Main Methods:

  • A phase 3, randomized, assessor-blinded, multicenter study involving 78 children aged 9-16.
  • Participants were randomized to receive different doses of SPMC or PEG.
  • Bowel preparation quality was assessed using the modified Aronchick Scale; tolerability and satisfaction were measured via questionnaire.

Main Results:

  • SPMC demonstrated comparable efficacy to PEG in achieving adequate bowel preparation across age groups.
  • Participants receiving SPMC (1 dose x 2) reported significantly higher ease of drinking compared to PEG.
  • Treatment-emergent adverse events were less frequent with SPMC compared to PEG.

Conclusions:

  • SPMC is an efficacious and safe bowel preparation option for pediatric patients undergoing colonoscopy.
  • SPMC offers improved tolerability over PEG, enhancing patient experience.
  • This study supports SPMC as a viable alternative for pediatric bowel preparation.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
788
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
448
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
528
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
427
Lower GI Series: Barium Enema01:23

Lower GI Series: Barium Enema

A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
836